Pfizer sees Strong Prospects Based on Rapid Integration of Pharmacia and Expanded Product and R&D Opportunities STOCKHOLM, Sweden and NEW YORK, June 18, 2003 (PRIMEZONE) -- Pfizer (NYSE:PFE): - Estimates 16 Percent Compounded Annual Growth in Adjusted Diluted EPS* Between 2002-2004; Pharmacia Acquisition To...